Additional studies using nude mice bearing U-87MG tumors confirmed site-specific accumulation of the developed HA-targeted liposomes treatment was correlated with effective inhibition of tumor growth (to just 12.7% of the control group tumor size) and a decrease of the cell proliferation marker Ki-67 [199]. The gene discussed is MKI67; the disease is neoplasm.